4.8 Article

Role of BAX in the apoptotic response to anticancer agents

Journal

SCIENCE
Volume 290, Issue 5493, Pages 989-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.290.5493.989

Keywords

-

Funding

  1. NCI NIH HHS [CA 43460, CA 57345, CA 62924] Funding Source: Medline

Ask authors/readers for more resources

To assess the role of BAX in drug-induced apoptosis in human colorectal cancer cells, we generated cells that Lack functional BAX genes. Such cells were partially resistant to the apoptotic effects of the chemotherapeutic agent 5-fluorouracil, but apoptosis was not abolished. In contrast, the absence of BAX completely abolished the apoptotic response to the chemopreventive agent sulindac and other nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibited the expression of the antiapoptotic protein Bcl-X-L, resulting in an altered ratio of BAX to BcL-X-L and subsequent mitochondria-mediated cell death. These results establish an unambiguous role for BAX in apoptotic processes in human epithelial cancers and may have implications for cancer chemoprevention strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available